Pharmacist-physiotherapist Collaborative Management for Early Knee Osteoarthritis

Condition(s) studied

Investigational drug(s) / intervention(s)

Pharmacy-Physiotherapy Intervention: Pharmacists will provide comprehensive 1:1 patient care, including a complete patient assessment and medication review, provide specific drug therapy recommendation(s) using shared decision making (SDM), and provide patient education, including further written materials. Participants will be offered either individual or group physiotherapy sessions at the a private clinic.

Study summary

Osteoarthritis (OA) is a slowly progressive chronic condition that is associated with aging and is characterized as joint pain. Individuals with early-stage OA usually do not seek medical attention. If and when they do, patients more often present to a pharmacy for over-the-counter medications.

The investigators want to leverage community pharmacists' accessibility and scope of practice to best support patients with early knee OA. Given there are no disease-modifying treatments for OA, treatment guidelines center on patient education, self-management, and exercise, with medications playing a supporting role. Self-management is an effective strategy that provides a solid foundation for managing this progressive chronic condition and health care professionals like physiotherapists and pharmacists can help with the development and application of these skills.

Eligibility

Primary outcome measure(s)

• Disease specific self-report measure for OA — Baseline, Post Intervention (3 & 6 month after baseline)
  The Knee Injury in OA Outcome Score (KOOS) from 0-100 where a higher score is a better outcome.

Trial sites (1)

More University of Alberta trials in Canada

Other trials for the same condition